Log In


Company Name : Taro Pharmaceutical Industries Ltd.

Saturday, February 3, 2018 4:46PM IST (11:16AM GMT)


Taro to Announce Third Quarter Results on February 7, 2018

HAWTHORNE, N.Y., United States

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2017, after the close of market on Wednesday, February 7, 2018.


The release will be accessible on Taro’s website at www.taro.com.


About Taro


Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.





Click here for Media Contact Details

Taro Pharmaceutical Industries Ltd.
Mariano Balaguer
VP, Chief Financial Officer
William J. Coote
AVP, Business Finance, Treasurer and Investor Relations

More News from Taro Pharmaceutical Industries Ltd.

21/05/2018 11:10AM

टैरो ने 31 मार्च 2018 को समाप्त वर्ष के लिए परिणाम उपलब्‍ध कराये

टैरो फार्मास्‍युटिकल इंडस्‍ट्रीज लिमिटेड. (एनवाईएसई: टैरो) (“टैरो” अथवा “कंपनी”) ने आज 31 मार्च 2018 को समाप्‍त तिमाही और वर्ष के वित्‍तीय परिणाम उपलब्‍ध ...

18/05/2018 5:30PM

Taro Provides Results for Year Ended March 31, 2018

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2018.   Quarter ended March ...

14/05/2018 10:55AM

टैरो 17 मई, 2018 को करेगा पूरे वर्ष के नतीजों की घोषणा

टैरो फार्मास्‍युटिकल इंडस्‍ट्रीज लिमिटेड (एनवाईएसई : टैरो) ने आज घोषणा की है कि इसने 31 मार्च 2018 को समाप्‍त वित्‍तीय वर्ष के लिए अपने वित्‍तीय नतीजे गुरुवार, 17 मई 2018 को घोषित करने की ...

Similar News

25/05/2018 10:00AM

Chasing a Dream of Inclusive Society - National Organisation for Social Empowerment

India has progressed in every sphere of life including the fields of education, healthcare sector, industrial sector and private sector, but when it comes to providing equal opportunity to poor and downtrodden, we are ...

No Image

24/05/2018 2:45PM

Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease

Data presented at American Thoracic Society meeting underpin the benefits of Spiolto® Respimat® for physical activity in COPD1,2 Study published in American Journal of Respiratory and Critical Care Medicine ...